United Therapeutics Corporation Tax Withholding Paid on Stock Awards
United Therapeutics Corporation (UTHR) reported Tax Withholding Paid on Stock Awards of $58.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $500.00K, a 150.00% increase year-over-year.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $58.30M, a 281.05% increase year-over-year.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $600.00K, a 100.00% increase year-over-year.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $500.00K, a 25.00% increase year-over-year.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for fiscal 2025 was $16.60M, a 36.07% increase from fiscal 2024.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for fiscal 2024 was $12.20M, a 11.59% decline from fiscal 2023.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for fiscal 2023 was $13.80M, a 21.05% increase from fiscal 2022.
- United Therapeutics Corporation payment, tax withholding, share-based payment arrangement for fiscal 2022 was $11.40M, a 5.56% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $58.80M 10-Q · filed 2026-08-05 | $59.40M derived: sum of 3 quarters · filed 2026-08-05 | $59.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $58.30M 10-Q · filed 2026-05-06 | $58.90M derived: sum of 2 quarters · filed 2026-05-06 | $59.40M derived: sum of 3 quarters · filed 2026-05-06 | $59.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.10M derived: sum of 2 quarters · filed 2026-02-25 | $1.30M derived: sum of 3 quarters · filed 2026-08-05 | $16.60M 10-K · filed 2026-02-25 |
| 2025-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $700.00K derived: sum of 2 quarters · filed 2026-08-05 | $16.00M 10-Q · filed 2025-10-29 | $16.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.50M 10-Q · filed 2026-08-05 | $15.80M derived: sum of 3 quarters · filed 2026-08-05 | $16.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $15.30M 10-Q · filed 2026-05-06 | $15.60M derived: sum of 2 quarters · filed 2026-05-06 | $16.00M derived: sum of 3 quarters · filed 2026-05-06 | $16.10M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $700.00K derived: sum of 2 quarters · filed 2026-02-25 | $800.00K derived: sum of 3 quarters · filed 2026-02-25 | $12.20M 10-K · filed 2026-02-25 |
| 2024-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $500.00K derived: sum of 2 quarters · filed 2025-10-29 | $11.90M 10-Q · filed 2025-10-29 | $12.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $11.50M 10-Q · filed 2025-07-30 | $11.60M derived: sum of 3 quarters · filed 2026-02-25 | $11.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $11.40M 10-Q · filed 2025-04-30 | $11.50M derived: sum of 2 quarters · filed 2026-02-25 | $11.70M derived: sum of 3 quarters · filed 2026-02-25 | $11.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $300.00K derived: sum of 2 quarters · filed 2026-02-25 | $300.00K derived: sum of 3 quarters · filed 2026-02-25 | $13.80M 10-K · filed 2026-02-25 |
| 2023-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $200.00K derived: sum of 2 quarters · filed 2024-10-30 | $13.70M 10-Q · filed 2024-10-30 | $13.70M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $13.50M 10-Q · filed 2024-07-31 | $13.50M derived: sum of 3 quarters · filed 2025-02-26 | $13.80M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $13.50M 10-Q · filed 2024-05-01 | $13.50M derived: sum of 2 quarters · filed 2025-02-26 | $13.80M derived: sum of 3 quarters · filed 2025-02-26 | $13.80M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $300.00K derived: sum of 2 quarters · filed 2025-02-26 | $300.00K derived: sum of 3 quarters · filed 2025-02-26 | $11.40M 10-K · filed 2025-02-26 |
| 2022-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $300.00K derived: sum of 2 quarters · filed 2023-11-01 | $11.40M 10-Q · filed 2023-11-01 | $11.60M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $11.10M 10-Q · filed 2023-08-02 | $11.30M derived: sum of 3 quarters · filed 2024-02-21 | $11.50M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $11.10M 10-Q · filed 2023-05-03 | $11.30M derived: sum of 2 quarters · filed 2024-02-21 | $11.50M derived: sum of 3 quarters · filed 2024-02-21 | $11.70M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $400.00K derived: sum of 2 quarters · filed 2024-02-21 | $600.00K derived: sum of 3 quarters · filed 2024-02-21 | $10.80M 10-K · filed 2024-02-21 |
| 2021-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $400.00K derived: sum of 2 quarters · filed 2022-11-02 | $10.60M 10-Q · filed 2022-11-02 | $10.70M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $10.40M 10-Q · filed 2022-08-03 | $10.50M derived: sum of 3 quarters · filed 2023-02-22 | $10.60M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $10.20M 10-Q · filed 2022-05-04 | $10.30M derived: sum of 2 quarters · filed 2023-02-22 | $10.40M derived: sum of 3 quarters · filed 2023-02-22 | $10.50M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $200.00K derived: sum of 2 quarters · filed 2023-02-22 | $300.00K derived: sum of 3 quarters · filed 2023-02-22 | $3.70M 10-K · filed 2023-02-22 |
| 2020-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $200.00K derived: sum of 2 quarters · filed 2021-11-03 | $3.60M 10-Q · filed 2021-11-03 | $3.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $3.50M 10-Q · filed 2021-08-04 | $3.50M derived: sum of 3 quarters · filed 2022-02-24 | $3.70M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.40M 10-Q · filed 2021-05-05 | $3.40M derived: sum of 2 quarters · filed 2022-02-24 | $3.60M derived: sum of 3 quarters · filed 2022-02-24 | $3.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $200.00K derived: sum of 2 quarters · filed 2022-02-24 | $200.00K derived: sum of 3 quarters · filed 2022-02-24 | $2.10M 10-K · filed 2022-02-24 |
| 2019-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $200.00K derived: sum of 2 quarters · filed 2020-10-28 | $2.10M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.90M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $1.90M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |